NCT01587833View on ClinicalTrials.gov

WEUKBRE5559: IMI PROTECT: Benzodiazepines & Fracture

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Anxiety Disorders
Interventions
DRUG

Benzodiazepine (BZD) use, defined by ATC codes

BZD prescription during the study period between January 1, 2001 and December 31, 2009

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY